Ysios Capital

Ysios Capital


search

A- A+

Buy Avodart, where to buy Nolvadex is actively used for the treatment of the breast cancer, by women during menopause. buy Atenolol online without a prescription

 LinkedIn Ysios Capital   Twitter Ysios Capital   RSS Ysios Capital
  • about us
  • management team
  • investment philosophy
  • portfolio
  • news & events
  • ysios investors
  • contact
  •  
  • subscribe to our newsletter
  •  
  • Ysios Fellowship Program
portfolio

Portfolio

  • ysios current portfolio
    • AELIX Therapeutics
    • AM Pharma
    • Anaconda Biomed
    • Aura Biosciences
    • Babyscripts
    • Rainier
    • CorWave
    • CVRx
    • DermaLumics
    • Galecto Biotech
    • Inbiomotion
    • Kala Pharmaceuticals
    • LAVA Therapeutics
    • MedLumics
    • Minoryx Therapeutics
    • Ona Therapeutics
    • Oxthera
    • Sanifit
    • SparingVision
    • Splice Bio
    • Synendos Therapeutics
    • VarmX
    • Vivet Therapeutics
    • Xeltis
  • ysios historical portfolio
    • Biovex
    • Cardoz
    • Endosense
    • Prexton Therapeutics
    • Sabirmedical
    • STAT-Diagnostica
    • TiGenix

Sanifit

Sanifit is a clinical-stage biopharmaceutical company focused on the development of SNF472, an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis.
 
 
Sanifit_logo Portfolio Ysios Capital
 

Details
Laboratoris Sanifit
Parc Bit
Building Naorte – PB4
Palma de Mallorca,07121
Spain
www.sanifit.com

 
Sanifit news

10.02.21
Sanifit Granted Orphan Drug Designation by the FDA for SNF472 for the Treatment of Peripheral Arterial Disease in Patients with End-stage Kidney Disease

12.10.20
Sanifit to Present New Data on SNF472 for Vascular Calcification at the American Society of Nephrology Kidney Week 2020

20.08.20
Sanifit Appoints Adam Levy as Chief Financial Officer



Read more
site map
privacy policy
legal notice
cookies policy

© 2021 Ysios Capital

supported by
EIF EC
members of
ascri evca pri
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. For more information on cookies check the legal notice I agree
Privacidad y política de Cookies